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TECHNOLOGICAL CHANGE IN THE EUROPEAN UNION:
KEY ISSUES INCLUDING COMMONALITY OF STANDARDS,
INTEGRATION AS PROMOTING CHANGE, AND IMPACT OF
CHANGE ON A UNIFIED ECONOMIC GROUPING
Richard Wainwright*
I am a lawyer speaking after a very fascinating series of presentations by
economists, and I am the lone European - still a European - I have not yet
migrated, compared with a lot of North Americans.
I hope you will make allowances for all of that. As you have probably
gathered, I am a government official. I work for the European Commission. I
have been there for nearly twenty-five years. I am one of the old school of
workers who stays more than two and a half years at a job. But, before that, I
worked for a British oil company, The British Petroleum Company, and I
have also worked in British government. I worked in a private capacity as a
barrister in England. I have seen a little bit of the rest of the world.
I should also say that, though I am here as an employee of the European
Commission, I have to give the usual "health warning," which we are re-
quired to do on these occasions. I am speaking in a personal capacity, and I
am not giving the official line of the European Union, European Communi-
ties, the European Commission, or whichever other institution you would
like to call it.
What I have decided to do is to speak to you about a particular issue
which has caused a great many problems and stimulated much debate. In
fact, it is even causing a great deal of problems and debate within the Euro-
pean Union. This is the debate about genetic engineering and the questions of
the effects or non-effects of genetic engineering on foodstuffs.
I appreciate this is, in a sense, a single-issue topic, but it does give rise to
a lot of general questions about the way Europe operates as a regulator. It
also gives rise to a certain number of interesting questions about the internal
distinctions within Europe, and also the differences, as far as they exist, be-
tween Europe and North America, which is a direct economic concern to a
* Mr. Wainwright is the Principal Legal Advisor for the Commission of the European
Community. He is head of the Internal Market Team, with responsibility for issues related to
technical harmonization, public procurement, telecommunications, the environment, customs,
and industrial affairs. He graduated with honors from Oxford University, earning a B.A. de-
gree, and thereafter a law degree from the Inns of Court School of Law.
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number of big food processing companies in the United States and North
America.
But I should emphasize that this is just an example, this story I am going
to tell. And in the time that is left to us, I would be very happy to talk to you,
answer questions, or discuss with you any other more burning topics in rela-
tion to Europe. For example, in the same type of area, we could discuss hor-
mones in beef, or, perhaps more generally, the resignation of the European
Commission, my bosses, if you prefer, what effect it has, if any at all, on the
ongoing work in Europe; or, indeed, things much more worldly, like the war
in Kosovo.
Let us get back to genetic engineering. First, what is it? The definition
given by the Organization for Economic Cooperation and Development
(OECD), in a report they made in 1992, is as follows: "a technology includ-
ing the component DNA technology which is used to isolate genes from an
organism, manipulate them in the laboratory and inject them again into an-
other organism." This gives rise to an organism sometimes called a geneti-
cally modified organism. It is a technology which unquestionably has an
enormous potential to improve crop yields and production by, for example,
creating useful characteristics for plants and animals, such as making them
resistant to insects and giving then an enhanced flavor or a longer shelf life.
In 1989, it was estimated again by the OECD that by the year 2000, the
value of agriculture biotechnology, including genetic engineering, could be
as much as 100 billion dollars at farm level. This figure does not sound very
big in relation to the capitalization of Microsoft, but for farmers, it is quite a
lot of money.
This discussion revolves around three different levels of products. First,
there are basic agriculture products, things like long-life tomatoes, sometimes
called Flavr Sav rs.1 Secondly, we have insect-resistant maize and soybeans,
which are resistant to herbicides, and third, there are processed products that
may contain genetically engineered characteristics, things like tomato puree,
which comes from long-life tomatoes, or any processed foods which use ge-
netically engineered foods, such as soybeans or com.
Why are these products regulated? In fact, they are regulated not just in
Europe, but in North America and other parts of the world. They are regu-
lated because there is a perceived risk that there may be some injury or dam-
age caused to other plants, for example, by increasing the insect resistance to
herbicides. This could also be of harm to animals or humans, or by increasing
resistance to certain antibiotics, it could interfere with medical treatment by
antibiotics. There is a perceived need for government to regulate genetic en-
I Flavr Sav'r tomatoes, the first genetically altered food approved in the United States,
are produced by Calgene, a U.S. company.
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gineering, either at the reproduction stage, the trade of these products, or at
the consumption level.
As far as the European Union is concerned, there is a one main rule
which was adopted in 1990, which is called the directive on the so-called
deliberate release into the environment of genetically modified organisms.
2
This directive was adopted as a means of harmonizing internal markets. In
other words, it was meant to counteract a perceived and actual threat that the
different Member States of the European Union would go their own ways
and have their own systems for authorizing the testing and marketing of ge-
netically engineered products. This was adopted as an instrument for harmo-
nizing the internal market, but it also had to take into account the underlying
preoccupation with protecting human health and the environment. It was
based on the concept of deliberate release - any intentional introduction into
the environment without a provision for containment in order to limit its
contact with the environment or the population, a non-research operation, for
example. Certainly, the most obvious example of the most deliberate release
would be the sale or marketing of a genetically engineered product.
Under the suggestion of the directive, notification has to be made by the
company that wants to make the sale; and they have to get consent for their
product, a little bit like you would if you wanted to put a pharmaceutical
product on the market. You would have to notify the FDA for consent and
conditions. Under the typical hybrid system, which was adopted under this
directive, the notification initially has to be sent to the national authority,
normally, the national authority where the company is established, which
then has the responsibility of looking for any flaws and rejecting the applica-
tion. If the authority thinks there are good grounds for accepting the applica-
• * 3
tion, it then moves on to a different plane.
The documentation is sent across to the European Commission, the other
Member States are informed. There is a complicated system with time limits
of confrontation and resolution if any conflicts arise. Ultimately, barring con-
flicts, it leads finally to a positive decision by the Commission to recommend
the release of this particular product. In that case, the Commission will notify
the original national authority which received the notification, telling them
that the product may be placed on the market. Once this has been done, that
product - and this is key from the point of view of the European Union - has
a right and principle within the right to be put on the market anywhere within
the European Union and to circulate freely within the European Union. There
is, however, in the text of the directive a so-called safeguard clause that al-
2 See Directive 90/220/EEC 1990 O.J. (L. 117) 15.
3 See Marsha A. Echols, Food Safety Regulation in the European Union and the United
States: Different Cultures, Different Laws, 4 COLUMBIA J. EUROPEAN L. 526, 537-38 (1998).
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lows a provision that, even though a product has an authorization, can restrict
or prohibit its use if it shows that there is still a risk to human health and/or
the environment. There is, then, another procedure for consultation and
eventual resolution.
How do these rules apply within the European Community? Under the di-
rective, a number of positive directions have been taken by the Commission
permitting the placing of genetically modified organisms on the market. But
there are two particular cases which have given rise to a considerable amount
of controversy which I would like to examine with you. They are of interest
in North America, and they are also illustrative of the sorts of problems
which still remain, particularly in Europe, when we are faced with new tech-
nologies, particularly new technologies in the field of food processing. There
are still some rather difficult consumer resistances to be overcome.
The first case which I want to discuss involves a soybean engineered in
the United States to be resistant to a particular herbicide. As far as Europe
was concerned, the product went through all the proper hoops, and it was
finally approved by the Commission on exhibition from the United Kingdom
in April of 1996. In the reasoning of the decision, which was published for
the public in the official journal, it was stated there was no reason to believe
there could be any adverse effects from the soybeans on human health or the
environment. There were no safety reasons to justify the segregation of this
product from any other soybeans, and there were no safety reasons for any
special labeling of this product.
This decision raised a storm of protests from a number of environmental
groups within Europe, such as Greenpeace and Friends of the Earth, and also
from some consumer groups. The consumer groups were particularly preoc-
cupied with the decision that the product required no particular labeling ei-
ther on the product itself nor on the final product into which this soybean
would go.
The second very controversial product being authorized by the Commis-
sion was a maize plant, a corn plant, which was developed in Switzerland; it
is now called Novatas, I think. It was designed to protect itself against a par-
ticular kind of pest. The document for this product was submitted to the
European Commission by France, and the file itself proved even more con-
troversial. The scientific evidence given to the European Commission was in
favor of a positive decision, but that is not sufficient. The matter also has to
be considered by the Regulatory Committee, which is a committee of repre-
sentatives of the Member States who advise the Commission when they are
making decisions such as this. This committee did not give a positive verdict.
Under the system as it operates, the Commission has powers delegated to it
by the Parliament and the Council. If they do not get a positive vote, the
[Vol. 25:81 1999]
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matter has to go back to the Council for a final decision. The matter finally
went back to the Commission, who looked at further scientific evidence,
which still confirmed that there were no safety or health risks. Finally, in
February of 1997, the Commission authorized putting this product on the
market. It was communicated to the French authorities that the maize was
authorized and could be used throughout the European Union.
Despite this, two Member States, Luxembourg and Austria, invoked the
safeguard clause mentioned earlier, which allows them to prevent putting a
product on the market in certain instances. The Commission then had to
make a decision about that. The Consultative Committee, again, could not
agree, and the matter again went back to the Commission. Currently, the
matter is still in the air, at least as far as these safeguard clauses are con-
cerned.
As just one further twist to this story, the French Consulate State also was
seized by the environmental group Greenpeace sometime during last year,
and it actually provisionally banned putting this product on the market in
France and posed some interpretation questions to the European Court, which
now has the case before it. That will probably take another year as well.
As far as the Novatas maize is concerned, they are in a difficult political
regulatory situation, one of which is, of course, unsatisfactory for the pro-
ducer of this product who invested, no doubt, many millions of dollars, if not
more, in its development.
I would like to come back to the question of labeling because labeling of
the foods produced from genetically engineered products has become proba-
bly the key issue which may or may not lead to a solution of the dilemma
within which we find ourselves. I should say that, until recently, the Com-
munities had no rules requiring labels on food produced from genetically
modified organisms. I mention this fact because it was felt that there were no
safety grounds, either human health or environmental safety grounds, within
the sense of this directive. The directive itself covered the ingredient, the
bean or the seed, and not the final processed product.
There has been a lot of political pressure over this issue from the Euro-
pean Parliament and from a number of non-governmental organizations. Be-
cause of this, a number of Member States are starting to go their own way.
The Committee is requiring, despite the express rules of the directive, that
there be such labeling. This is particularly important, getting back to the soy-
bean, because more than half, it seems, of processed foods on the European
market contain soybeans or derivatives of soybeans.
The Commission, which is an executive committee with some political
function, could not resist this pressure. It did come up with a series of rules,
first in September of 1997, and finally adopted a year later in September of
5
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1998, which required that there should be a specific mention on the final
product stating that it been raised from genetically modified soil or produced,
as the case may be, with additives and some flavorings.
This exclusion was criticized by the environmentalists, who claimed that
a number of products escaped the labeling requirements, such as oils, fats,
and chocolates. The suppliers, of course, are very unhappy with the new
regulations because it is well-known, or it seems to be well-known, that the
European consumer tends to be reluctant, for a rather complicated series of
psychological and historical reasons, to buy food if it states clearly on the
label that it is made from anything that is genetically modified.
A number of firms have started to set aside special product lines for sup-
ply to the European market which would contain nothing but non-genetically
modified corn, maize, or other products. But, again, there is a difficulty be-
cause the tests that certify this are, apparently, not very reliable, and there is a
risk that the product could fall through the trap, even if the supplier takes a
number of precautions to avoid this. Indeed, most retailers in European cities
are aware of the hesitation by the consumer, and they make it very clear they
will not buy these products if they are required to put this information on the
label.
That is a little bit of a lesson, perhaps, not a very encouraging one, of the
effects of technological change on Europe. It also indicates the reaction of
European politicians and the consumer regulators to technological change. I
do not want to suggest necessarily that this is the only case, nor do I want to
suggest that it is typical, but I think it is something that you have to bear in
mind, particularly when you are operating in a sector which is, apparently,
for the European consumer, as sensitive as the food sector.
This genetic engineering saga is a classic example of a conflict between
what is sometimes called the anger industry on the one hand, and the con-
sumer or the environmentalist lobby on the other. It is a conflict which we
see in other areas as well, particularly an area or issue which has been judged
by the World Trade Organization. On the 13th of May, the European Union
will have to take some action in order to comply with the provision of the
World Trade Organization, that is the problem of hormones in beef, hor-
mones which are added to cattle as growth promoters.4
Supporters of genetic engineering argue that there is a potential for job
creation. There is even a possibility of increasing the quality of products for
4 See E.C. -Measures Concerning Meat & Meat Products (Hormones), WT/DS48/AB/R,
Jan. 16, 1998. The European Union asked to settle the dispute with monetary compensation
for their non-compliance. The case is now before the original dispute resolution panel to
decide the amount of the actual settlement. See Overview of the State of Play of WTO Disputes
(visited July 14, 1999) <http://www.wto.org/wto/dispute/bulletin.html>.
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the consumer. It is accepted that, because of the risks to health and the envi-
ronment, the sector must be regulated. But they insist that these regulations
must be based on a scientific assessment of the real risk and safety, not on
vague fears. Because of the large investment, they need great certainty. On
the other hand, environmentalists and consumer groups, in particular, argue
that there are still dangers that are not properly understood. It cannot be
overestimated what the effect was on the food industry in Europe by the so-
called "BSE crises," the crises that arose from meat which comes from ani-
mals contaminated with this BSE disease, bovine spongiform encephalopa-
thy, more commonly known as "mad cow disease.' 5 It was mostly a problem
in the United Kingdom. Despite all the scientific protestations and arguments
about being responsible for a particular nasty and fatal disease called Jacobs
Disease, this saga of the early 1990s has had a very marked effect on both the
regulatory and the consumer scene.
It is probably fair to say now that the general public does not trust the sci-
entists anymore in Europe. They do not trust the scientists when they say
something is safe and that there is no problem for the consumer or for the
environment. Above all, what the consumers are saying is that they are enti-
tled to know what they are eating; they are entitled to know whether the food
they are eating is being produced from a genetic engineering process or not,
and they should be able to chose whether to eat that food or not. In between
these two camps, by the regulatory bodies and, particularly, both in the
Commission and the Member States, they are very uncertain and very nerv-
ous. They do not like to entrust themselves entirely to the scientific commu-
nity and the scientific assessment, but, of course, they do not really have any
other solid basis upon which to act.
The only thing which seems very clear is that they have been moving to-
ward compulsory labeling. This in itself is a relatively negative conclusion
for the industry, because it will quite clearly have a significant effect on the
growth of this industry at the retail level in Europe, and perhaps even more
so, at the level of research and production. It seems quite clear that this is
going to give another boost to what one might call the general issue of re-
search and development, particularly in the areas of biochemistry and genetic
engineering, which is going to mean that Europe is going to fall even further
behind in this field than the United States and, perhaps, Canada, as well.
5 See generally Michael Janofsky, 25 Million Pounds of Beef is Recalled, N.Y. TIMES,
Aug. 22, 1997, at A6.
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